The estimated Net Worth of Rose Di Martino is at least 13.2 千$ dollars as of 16 July 2024. Rose Martino owns over 1,000 units of abrdn World Healthcare Fund stock worth over 13,170$ and over the last few years Rose sold THW stock worth over 0$.
Rose has made over 4 trades of the abrdn World Healthcare Fund stock since 2024, according to the Form 4 filled with the SEC. Most recently Rose bought 1,000 units of THW stock worth 15,530$ on 16 July 2024.
The largest trade Rose's ever made was buying 1,000 units of abrdn World Healthcare Fund stock on 16 July 2024 worth over 15,530$. On average, Rose trades about 1,000 units every 0 days since 2024. As of 16 July 2024 Rose still owns at least 1,000 units of abrdn World Healthcare Fund stock.
You can see the complete history of Rose Martino stock trades at the bottom of the page.
Rose's mailing address filed with the SEC is C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA, PA, 19103.
Over the last 9 years, insiders at abrdn World Healthcare Fund have traded over 0$ worth of abrdn World Healthcare Fund stock and bought 45,572 units worth 663,230$ . The most active insiders traders include Daniel R Omstead、Jeffrey Allen Bailey、Michael W Bonney. On average, abrdn World Healthcare Fund executives and independent directors trade stock every 223 days with the average trade being worth of 40,010$. The most recent stock trade was executed by Bill Maher on 14 August 2024, trading 1,000 units of THW stock currently worth 13,030$.
tekla life sciences investors is a closed-ended equity mutual fund launched and managed by tekla capital management llc. the fund invests in public equity markets across the globe. it seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. the fund primarily invests in growth stocks of small cap companies. it employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. the fund benchmarks the performance of its portfolio against the nasdaq biotech index and the s&p 500 index. it was form
abrdn World Healthcare Fund executives and other stock owners filed with the SEC include: